跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG
Approved
THERAPEUTIC
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG
BORYUNG CORPORATION
🇸🇬 Health Sciences Authority
Approval Date
Sep 26, 2019
Approval ID
8e5045e3a25c1136
Company
BORYUNG CORPORATION
Type
Therapeutic
Approval Details
Approval Id
8e5045e3a25c1136
Drug Name
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG
Product Name
KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG
Approval Number
SIN15818P
Approval Date
2019-09-26
Registrant
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C03AA03, C09CA10
Atc Item Name
xc 03 aa 03, c 09 ca 10
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
Fimasartan Potassium Trihydrate eqv Fimasartan Potassium
60.00 mg
Hydrochlorothiazide
12.5 mg
Fimasartan Potassium Trihydrate eqv Fimasartan Potassium
60.00 mg
Hydrochlorothiazide
12.5 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 26, 2019
Approval ID
8e5045e3a25c1136
Type
Therapeutic
Back to HSA Approvals
